Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2023 08:00 ET | Source: Prime Medicine, Inc.

Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

-- Announced preclinical data providing further proof-of-concept for Prime Editing’s ability to achieve restoration of genetic function, as well as new preliminary safety analyses demonstrating no...
February 27, 2023 08:00 ET | Source: Prime Medicine, Inc.

Prime Medicine to Present at Cowen 43rd Annual Health Care Conference

CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
January 09, 2023 07:00 ET | Source: Prime Medicine, Inc.

Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities

-- New preclinical data in Friedrich’s ataxia and cystic fibrosis provided further proof-of-concept for Prime Editing’s ability to achieve restoration of genetic function ---- New preliminary safety...
January 03, 2023 08:00 ET | Source: Prime Medicine, Inc.

Prime Medicine to Present at 41st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
October 24, 2022 17:30 ET | Source: Prime Medicine, Inc.

Prime Medicine Announces Closing of Upsized Initial Public Offering

CAMBRIDGE, Mass., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...